Fundraising Fox
Viva in Vitro
Murcia, ES · 2 known investors
Find your way into Viva in Vitro
Sign up to see every warm intro you have to Viva in Vitro
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Viva in Vitro team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Viva In Vitro Diagnostics is a biotech company that researches and develops diagnostic solutions and services focused on the NLRP3 inflammasome and inflammatory processes, including biomarkers for early prognosis and patient stratification in sepsis. A spin-off of Murcia's biomedical research institute (IMIB), it serves hospitals, laboratories, and research centers, with its own lab in the Parque Científico de Murcia, Spain.
Founders & leadership
PP
Pablo PelegrínFounder & Scientific Advisor to the Management CommitteePablo Pelegrín is a researcher with expertise in innate immunity and inflammatory processes, including inflammasome biology, purinergic signaling, and biomarkers related to sepsis and inflammatory conditions. He founded Viva In Vitro Diagnostics as a spin-off of Spain's IMIB biomedical research institute.
AV
Antonio VilaplanaCEO
JG
Joaquín Gómez-MoyaPresidentJoaquín Gómez-Moya is President and Chairman of Viva In Vitro, a biotech diagnostics company focused on NLRP3 inflammasome research and inflammatory biomarkers. He holds board and advisory positions in life sciences and technology ventures, with prior experience in venture capital fundraising, business scaling, and international commercialization across multiple countries.
TV
Toni VilaplanaGeneral DirectorToni Vilaplana is General Director of Viva In Vitro Diagnostics, a biotech diagnostics company developing solutions for inflammatory biomarkers and sepsis prognosis. He has over 25 years of experience in general management, corporate finance, and business transformation, with more than a decade advising on M&A transactions and corporate restructurings.
VC
Verónica Cánovas HernándezManager of Biotechnological Development
Investors · 2
Also in the syndicate · 1
Murcia Emprende
Funding
SEC filings, press & company announcements- Undisclosed amountthird roundJul 2024
Murcia Emprende
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Viva in Vitro do?
- Viva In Vitro Diagnostics is a biotech company that researches and develops diagnostic solutions and services focused on the NLRP3 inflammasome and inflammatory processes, including biomarkers for early prognosis and patient stratification in sepsis. A spin-off of Murcia's biomedical research institute (IMIB), it serves hospitals, laboratories, and research centers, with its own lab in the Parque Científico de Murcia, Spain.
- Who founded Viva in Vitro?
- Viva in Vitro was founded by Pablo Pelegrín, Carlos García-Palenciano.
- Who are Viva in Vitro's investors?
- Viva in Vitro's investors include Ship2B.
- Where is Viva in Vitro headquartered?
- Viva in Vitro is headquartered in Murcia, ES.